Distance Education Versus Usual Care Qualification in Asthma Care (RESPIRANET)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2010 by Hospital de Clinicas de Porto Alegre.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Karine Margarites Lima
Collaborator:
Federal University of Rio Grande do Sul
Information provided by (Responsible Party):
Karine Margarites Lima, Hospital de Clinicas de Porto Alegre
ClinicalTrials.gov Identifier:
NCT01595971
First received: May 9, 2012
Last updated: NA
Last verified: August 2010
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate the effectiveness of multifaceted educational interventions in the care of asthma, conducted remotely over the platform TelessaúdeRS in teams of the Family Health Strategy and the consequent clinical improvement patients.
| Condition | Intervention |
|---|---|
|
Asthma |
Behavioral: Continuing education Other: usual care |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Health Services Research |
| Official Title: | Distance Education Versus Usual Care in the Qualification of Asthma Care: A Cluster Randomized Clinical Trial - RESPIRANET |
Resource links provided by NLM:
Further study details as provided by Hospital de Clinicas de Porto Alegre:
Primary Outcome Measures:
- Symptom burden, measured as the number of self-reported asthma symptom days (ASD). ASD is based on 2 week recall. [ Time Frame: six months ] [ Designated as safety issue: Yes ]The definition of a symptom day includes presence of any of the four types of asthma symptoms: wheeze, cough, night time awakening ou shortness of breath. The results will be collected through the application of standardized questionnaires.
Secondary Outcome Measures:
- Asthma control [ Time Frame: 6 months ] [ Designated as safety issue: No ]Control of asthma will be evaluated by the excessive use of relief medication in the last month.
- Health care utilization [ Time Frame: 6 meses ] [ Designated as safety issue: No ]Proportion of unscheduled medical visits during the follow-up
- Proportion of patients in use inhaled corticosteroids [ Time Frame: 6 meses ] [ Designated as safety issue: No ]Use of inhaled corticosteroids assessed by the proportion of patients who require medication to prevent asthma symptoms that are in use of inhaled corticosteroids.
| Enrollment: | 467 |
| Study Start Date: | August 2010 |
| Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: continuing education
RESPIRANET is a multifaceted intervention directed at professionals of the Family Health Teams in the inner cities.Includes telemedicine, reminders, video conferences, educational materials for patients and consultants.
|
Behavioral: Continuing education
Includes telemedicine, reminders, video conferences, educational materials for patients and consultants.
Other Name: RESPIRANET
|
| Placebo Comparator: Usual Care |
Other: usual care
Received the usual care provided
|
Detailed Description:
Cluster-randomized trial with follow-up of 6 months. The aim of this study is to determine whether multifaceted interventions performed at a distance for the care of asthma symptoms reduce overhead, improve asthma control and qualify the care provided to patients.
Eligibility| Ages Eligible for Study: | 5 Years to 45 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Practice:Participate in the Telessaúde/RS. Minimal staff consisting of a general practitioner, nurse, nurse and community health agents (CHA), ability to give at least ten patients diagnosed with asthma, located in a municipality to make available for free inhaled medication (short-acting bronchodilators and corticosteroids ) for the treatment of asthma and willingness to participate in the study.
- Patients: 5 to 45 years with a diagnosis of asthma made by a physician and register at least one consultation for asthma or an asthma-related hospitalization during the year preceding the beginning of the study.
Exclusion Criteria:
- Patients with other chronic diseases with pulmonary complications such as tuberculosis, cancer and cystic fibrosis or those with severe mental illness
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01595971
Locations
| Brazil | |
| Hospital de clínicas de Porto Alegre | |
| Porto Alegre, Rio grande do sul, Brazil | |
Sponsors and Collaborators
Karine Margarites Lima
Federal University of Rio Grande do Sul
Investigators
| Study Chair: | Erno Harzheim, PHD | Federal University of Rio Grande do Sul |
More Information
Additional Information:
No publications provided
| Responsible Party: | Karine Margarites Lima, MD, Hospital de Clinicas de Porto Alegre |
| ClinicalTrials.gov Identifier: | NCT01595971 History of Changes |
| Other Study ID Numbers: | MED/FNS 774/08 |
| Study First Received: | May 9, 2012 |
| Last Updated: | May 9, 2012 |
| Health Authority: | Brazil: National Committee of Ethics in Research |
Keywords provided by Hospital de Clinicas de Porto Alegre:
|
Asthma Continuing education Primary health care |
Additional relevant MeSH terms:
|
Asthma Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases |
Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |
ClinicalTrials.gov processed this record on June 18, 2013